SlideShare a Scribd company logo
1 of 1
Download to read offline
Data-driven strategies for automated dispensing
cabinet (ADC) inventory optimization
Xander Miller and Michelle McCrea, RPh
Massachusetts General Hospital, Boston, MA
Background
Objectives
Acknowledgments
Challenges/LimitationsMonthly ADC Valuations
Methods
Future Work/Next Steps
Disclosure
• Authors of this presentation have the following to
disclose concerning possible financial or personal
relationships with commercial entities that may have a
direct or indirect interest in the subject matter of this
presentation:
Xander Miller - Nothing to disclose
Michelle McCrea – Nothing to disclose
•MGH has 46 distinct inpatient units for a total
of 999 inpatient beds
•Roughly 82% of the 10,189 daily doses are
dispensed from the 118 ADCs on these units
•This creates financial exposure for the
pharmacy, as these medications are “on
consignment” while stocked in the ADC
•At the start of this project, approximately $1.33
million worth of medications were routinely
stocked throughout the hospital ADCs
•Several ADCs contained in excess of $45,000
worth of medications
•Since medications stocked in ADCs are at
greater risk for expiring unused, we identified
this as an area for potential cost savings
•To reduce the total value of medications stored
in ADCs on inpatient units without reducing the
availability of medications
•An ADC inventory report was built in the central
automation server set to generate every
Monday night
•This report was exported into a spreadsheet,
where the data was cleaned and valuation data
was calculated for every item
•High cost items were identified and evaluated
for removal or reduction based on usage data
•If unused in the last 6 months, items were
removed from stock to be dispensed from
central pharmacy
•If used infrequently, usage data was
analyzed to determine a reduced par level
•Emergency medications, such as alteplase,
were never completely removed
•Par levels were reduced where appropriate
based on usage history and clinical judgment
•In May, MGH transitioned to EPIC, temporarily
pausing this project. There was a notable
upwards trend in valuations in the months
surrounding this transition, largely due to
staffing limitations
The authors would like to thank Jim Lund,
PharmD and April Madrigal, CPhT for their
assistance and support during this project
•ADC inventory optimization represents an
underutilized area of cost avoidance with
relatively easy implementation in many
hospitals
•Next steps at MGH include evaluating
medications for addition to the ADC inventory
with the goal of increasing the percentage of
doses dispensed from the ADC system to
reduce turnaround times
•Integration of ADC inventory maintenance to
pharmacy workflows, rather than the current
ad-hoc basis would further streamline this
continuous improvement process
•Increased use of systems such as those
offered by Omnicell and Pandora is currently
being explored to help automate fine-tuning of
par levels
Month Medication Valuation $ Reduction from Start % Reduction from Start
Oct-15 $1,331,195 -- --%
Nov-15 $1,273,507 $57,689 4%
Dec-15 $1,060,670 $270,525 20%
Jan-16 $1,032,786 $298,409 22%
Feb-16 $926,558 $404,638 30%
Mar-16 $952,005 $379,191 28%
Apr-16 $991,551 $339,645 26%
May-16 $967,296 $363,900 27%
Jun-16 $992,787 $338,409 25%
Jul-16 $1,012,648 $318,547 24%
Aug-16 $847,853 $483,343 36%
Sep-16 $855,862 $475,333 36%
Oct-16 $885,734 $445,461 33%
$1.33
$0.89
0%
5%
10%
15%
20%
25%
30%
35%
40%
45%
$-
$0.20
$0.40
$0.60
$0.80
$1.00
$1.20
$1.40
10/2015 11/2015 12/2015 1/2016 2/2016 3/2016 4/2016 5/2016 6/2016 7/2016 8/2016 9/2016 10/2016
PercentReductioninADCValuation
TotalADCValuation(Millions)
Monthly Valuation Percent Reduction

More Related Content

What's hot

Infusion Center Turnaround Presentation
Infusion Center Turnaround PresentationInfusion Center Turnaround Presentation
Infusion Center Turnaround PresentationMark Huizenga
 
Innovating health appropriate_technology_right_to_care
Innovating health appropriate_technology_right_to_careInnovating health appropriate_technology_right_to_care
Innovating health appropriate_technology_right_to_careAIDS Watch Africa
 
Managing Cost in the Era of Healthcare Reform
Managing Cost in the Era of Healthcare Reform  Managing Cost in the Era of Healthcare Reform
Managing Cost in the Era of Healthcare Reform Mikan Associates
 
Cost effectiveness analysis in health care planning
Cost effectiveness analysis in health care planningCost effectiveness analysis in health care planning
Cost effectiveness analysis in health care planningNayyar Kazmi
 
Human factors engineering strategies HY
Human factors engineering strategies HYHuman factors engineering strategies HY
Human factors engineering strategies HYRickettsia Rickettsii
 
Health Guide Book: Proving and Selling Your Value Story - Three Short Examples
Health Guide Book: Proving and Selling Your Value Story - Three Short ExamplesHealth Guide Book: Proving and Selling Your Value Story - Three Short Examples
Health Guide Book: Proving and Selling Your Value Story - Three Short ExamplesHealth Informatics New Zealand
 
2013 Navigate-cost containment in West Australian healthcare-our perspective
2013 Navigate-cost containment in West Australian healthcare-our perspective2013 Navigate-cost containment in West Australian healthcare-our perspective
2013 Navigate-cost containment in West Australian healthcare-our perspectiveNavigate Consulting Australia Pty Ltd
 
Successful deployment of PharmaNET in UK
Successful deployment of PharmaNET in UKSuccessful deployment of PharmaNET in UK
Successful deployment of PharmaNET in UKVarun Dinesh Patel
 
Successful deployment of PharmaNET in UK
Successful deployment of PharmaNET in UKSuccessful deployment of PharmaNET in UK
Successful deployment of PharmaNET in UKVarun Dinesh Patel
 
Pat o'byrne conference march 2011 final
Pat o'byrne conference march 2011 finalPat o'byrne conference march 2011 final
Pat o'byrne conference march 2011 finalInvestnet
 
Latest Learning and Resources for iCCM_Heaton
Latest Learning and Resources for iCCM_HeatonLatest Learning and Resources for iCCM_Heaton
Latest Learning and Resources for iCCM_HeatonCORE Group
 
Banner Health
Banner HealthBanner Health
Banner Healthlponssa
 
Medical Tecnologies Corporation (MTC)
Medical Tecnologies Corporation (MTC)Medical Tecnologies Corporation (MTC)
Medical Tecnologies Corporation (MTC)JosMaraCasaresMillet
 
Tka analysis 6 12-15
Tka analysis 6 12-15Tka analysis 6 12-15
Tka analysis 6 12-15Intralign
 
Simtegr8 presentation 7 day master
Simtegr8 presentation 7 day masterSimtegr8 presentation 7 day master
Simtegr8 presentation 7 day masterMarianne Bamkin
 
Translating Patient Experience into Health System Improvement
Translating Patient Experience into Health System ImprovementTranslating Patient Experience into Health System Improvement
Translating Patient Experience into Health System ImprovementDr Avnesh Ratnanesan (Avi)
 

What's hot (20)

Infusion Center Turnaround Presentation
Infusion Center Turnaround PresentationInfusion Center Turnaround Presentation
Infusion Center Turnaround Presentation
 
Innovating health appropriate_technology_right_to_care
Innovating health appropriate_technology_right_to_careInnovating health appropriate_technology_right_to_care
Innovating health appropriate_technology_right_to_care
 
Just in time compounding
Just in time compoundingJust in time compounding
Just in time compounding
 
Managing Cost in the Era of Healthcare Reform
Managing Cost in the Era of Healthcare Reform  Managing Cost in the Era of Healthcare Reform
Managing Cost in the Era of Healthcare Reform
 
Cost effectiveness analysis in health care planning
Cost effectiveness analysis in health care planningCost effectiveness analysis in health care planning
Cost effectiveness analysis in health care planning
 
Human factors engineering strategies HY
Human factors engineering strategies HYHuman factors engineering strategies HY
Human factors engineering strategies HY
 
Health Guide Book: Proving and Selling Your Value Story - Three Short Examples
Health Guide Book: Proving and Selling Your Value Story - Three Short ExamplesHealth Guide Book: Proving and Selling Your Value Story - Three Short Examples
Health Guide Book: Proving and Selling Your Value Story - Three Short Examples
 
2013 Navigate-cost containment in West Australian healthcare-our perspective
2013 Navigate-cost containment in West Australian healthcare-our perspective2013 Navigate-cost containment in West Australian healthcare-our perspective
2013 Navigate-cost containment in West Australian healthcare-our perspective
 
Successful deployment of PharmaNET in UK
Successful deployment of PharmaNET in UKSuccessful deployment of PharmaNET in UK
Successful deployment of PharmaNET in UK
 
Successful deployment of PharmaNET in UK
Successful deployment of PharmaNET in UKSuccessful deployment of PharmaNET in UK
Successful deployment of PharmaNET in UK
 
Pat o'byrne conference march 2011 final
Pat o'byrne conference march 2011 finalPat o'byrne conference march 2011 final
Pat o'byrne conference march 2011 final
 
Leveraging data into sustainable solutions
Leveraging data into sustainable solutionsLeveraging data into sustainable solutions
Leveraging data into sustainable solutions
 
Latest Learning and Resources for iCCM_Heaton
Latest Learning and Resources for iCCM_HeatonLatest Learning and Resources for iCCM_Heaton
Latest Learning and Resources for iCCM_Heaton
 
Banner Health
Banner HealthBanner Health
Banner Health
 
Medical Tecnologies Corporation (MTC)
Medical Tecnologies Corporation (MTC)Medical Tecnologies Corporation (MTC)
Medical Tecnologies Corporation (MTC)
 
Tka analysis 6 12-15
Tka analysis 6 12-15Tka analysis 6 12-15
Tka analysis 6 12-15
 
TxMD Sample
TxMD SampleTxMD Sample
TxMD Sample
 
HPRC's Complete Guide to Building a Business Case for Hospital Recycling
HPRC's Complete Guide to Building a Business Case for Hospital RecyclingHPRC's Complete Guide to Building a Business Case for Hospital Recycling
HPRC's Complete Guide to Building a Business Case for Hospital Recycling
 
Simtegr8 presentation 7 day master
Simtegr8 presentation 7 day masterSimtegr8 presentation 7 day master
Simtegr8 presentation 7 day master
 
Translating Patient Experience into Health System Improvement
Translating Patient Experience into Health System ImprovementTranslating Patient Experience into Health System Improvement
Translating Patient Experience into Health System Improvement
 

Similar to Midyear v7

Harnessing Digital Tools in Medicines Optimisation to tackle Health Inequalit...
Harnessing Digital Tools in Medicines Optimisation to tackle Health Inequalit...Harnessing Digital Tools in Medicines Optimisation to tackle Health Inequalit...
Harnessing Digital Tools in Medicines Optimisation to tackle Health Inequalit...Health Innovation Wessex
 
Patient Blood Management: Impact of Quality Data on Patient Outcomes
Patient Blood Management: Impact of Quality Data on Patient OutcomesPatient Blood Management: Impact of Quality Data on Patient Outcomes
Patient Blood Management: Impact of Quality Data on Patient OutcomesViewics
 
How to Engage Physicians in Quality/Safety Improvement Using Metrics
How to Engage Physicians in Quality/Safety Improvement Using MetricsHow to Engage Physicians in Quality/Safety Improvement Using Metrics
How to Engage Physicians in Quality/Safety Improvement Using MetricsWellbe
 
Market Development Strategy - IVD Hematological Oncology Assay
Market Development Strategy - IVD Hematological Oncology AssayMarket Development Strategy - IVD Hematological Oncology Assay
Market Development Strategy - IVD Hematological Oncology AssayReina Karunaratne
 
Generating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACOGenerating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACOTodd Berner MD
 
Transitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyTransitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyWes Chapman
 
Transfers of Care Around Medicine training session
Transfers of Care Around Medicine training sessionTransfers of Care Around Medicine training session
Transfers of Care Around Medicine training sessionInnovation Agency
 
Investing in an outpatient pharmacy
Investing in an outpatient pharmacyInvesting in an outpatient pharmacy
Investing in an outpatient pharmacyMark Currie
 
Best in-class Key Account Managers
Best in-class Key Account ManagersBest in-class Key Account Managers
Best in-class Key Account ManagersJean-Michel Peny
 
Clahrc ps cmeeting_21st_sept2015_spacer_project_cc
Clahrc ps cmeeting_21st_sept2015_spacer_project_ccClahrc ps cmeeting_21st_sept2015_spacer_project_cc
Clahrc ps cmeeting_21st_sept2015_spacer_project_ccNIHR CLAHRC West Midlands
 
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...Innovation Agency
 
Hassan Argomandkhah - electronic Transfer of Care to Pharmacy training session
Hassan Argomandkhah - electronic Transfer of Care to Pharmacy training sessionHassan Argomandkhah - electronic Transfer of Care to Pharmacy training session
Hassan Argomandkhah - electronic Transfer of Care to Pharmacy training sessionInnovation Agency
 
Pharmacoeconomis
PharmacoeconomisPharmacoeconomis
PharmacoeconomisAanchal46
 
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14CORE Group
 
3 the budget – pre paration and imple mentation
3 the budget – pre paration and imple mentation3 the budget – pre paration and imple mentation
3 the budget – pre paration and imple mentationChanukya Vanam . Dr
 
Working with Regulators: A Focus on CMS | June 24, 2014 | All Slides
Working with Regulators: A Focus on CMS | June 24, 2014 | All SlidesWorking with Regulators: A Focus on CMS | June 24, 2014 | All Slides
Working with Regulators: A Focus on CMS | June 24, 2014 | All SlidesCancerSupportComm
 
Clinical Analytics
Clinical AnalyticsClinical Analytics
Clinical AnalyticsMichael Bice
 
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...HFG Project
 

Similar to Midyear v7 (20)

Transforming Together - Allocation
Transforming Together - AllocationTransforming Together - Allocation
Transforming Together - Allocation
 
Harnessing Digital Tools in Medicines Optimisation to tackle Health Inequalit...
Harnessing Digital Tools in Medicines Optimisation to tackle Health Inequalit...Harnessing Digital Tools in Medicines Optimisation to tackle Health Inequalit...
Harnessing Digital Tools in Medicines Optimisation to tackle Health Inequalit...
 
Patient Blood Management: Impact of Quality Data on Patient Outcomes
Patient Blood Management: Impact of Quality Data on Patient OutcomesPatient Blood Management: Impact of Quality Data on Patient Outcomes
Patient Blood Management: Impact of Quality Data on Patient Outcomes
 
How to Engage Physicians in Quality/Safety Improvement Using Metrics
How to Engage Physicians in Quality/Safety Improvement Using MetricsHow to Engage Physicians in Quality/Safety Improvement Using Metrics
How to Engage Physicians in Quality/Safety Improvement Using Metrics
 
Market Development Strategy - IVD Hematological Oncology Assay
Market Development Strategy - IVD Hematological Oncology AssayMarket Development Strategy - IVD Hematological Oncology Assay
Market Development Strategy - IVD Hematological Oncology Assay
 
Generating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACOGenerating Quality Data through Collaborative Research with an ACO
Generating Quality Data through Collaborative Research with an ACO
 
Transitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyTransitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case Study
 
Transfers of Care Around Medicine training session
Transfers of Care Around Medicine training sessionTransfers of Care Around Medicine training session
Transfers of Care Around Medicine training session
 
Investing in an outpatient pharmacy
Investing in an outpatient pharmacyInvesting in an outpatient pharmacy
Investing in an outpatient pharmacy
 
Best in-class Key Account Managers
Best in-class Key Account ManagersBest in-class Key Account Managers
Best in-class Key Account Managers
 
Clahrc ps cmeeting_21st_sept2015_spacer_project_cc
Clahrc ps cmeeting_21st_sept2015_spacer_project_ccClahrc ps cmeeting_21st_sept2015_spacer_project_cc
Clahrc ps cmeeting_21st_sept2015_spacer_project_cc
 
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
ECO 11: Transfer of Care to Pharmacy - Hassan Argomandkhah, Chair of Pharmacy...
 
Hassan Argomandkhah - electronic Transfer of Care to Pharmacy training session
Hassan Argomandkhah - electronic Transfer of Care to Pharmacy training sessionHassan Argomandkhah - electronic Transfer of Care to Pharmacy training session
Hassan Argomandkhah - electronic Transfer of Care to Pharmacy training session
 
Pharmacoeconomis
PharmacoeconomisPharmacoeconomis
Pharmacoeconomis
 
Pharmacoeconomis
PharmacoeconomisPharmacoeconomis
Pharmacoeconomis
 
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14
Latest Learning and Resources for iCCM_Sarah Andersson_5.5.14
 
3 the budget – pre paration and imple mentation
3 the budget – pre paration and imple mentation3 the budget – pre paration and imple mentation
3 the budget – pre paration and imple mentation
 
Working with Regulators: A Focus on CMS | June 24, 2014 | All Slides
Working with Regulators: A Focus on CMS | June 24, 2014 | All SlidesWorking with Regulators: A Focus on CMS | June 24, 2014 | All Slides
Working with Regulators: A Focus on CMS | June 24, 2014 | All Slides
 
Clinical Analytics
Clinical AnalyticsClinical Analytics
Clinical Analytics
 
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
Financial Protection and Improved Access to Health Care: A Spotlight on Pharm...
 

Midyear v7

  • 1. Data-driven strategies for automated dispensing cabinet (ADC) inventory optimization Xander Miller and Michelle McCrea, RPh Massachusetts General Hospital, Boston, MA Background Objectives Acknowledgments Challenges/LimitationsMonthly ADC Valuations Methods Future Work/Next Steps Disclosure • Authors of this presentation have the following to disclose concerning possible financial or personal relationships with commercial entities that may have a direct or indirect interest in the subject matter of this presentation: Xander Miller - Nothing to disclose Michelle McCrea – Nothing to disclose •MGH has 46 distinct inpatient units for a total of 999 inpatient beds •Roughly 82% of the 10,189 daily doses are dispensed from the 118 ADCs on these units •This creates financial exposure for the pharmacy, as these medications are “on consignment” while stocked in the ADC •At the start of this project, approximately $1.33 million worth of medications were routinely stocked throughout the hospital ADCs •Several ADCs contained in excess of $45,000 worth of medications •Since medications stocked in ADCs are at greater risk for expiring unused, we identified this as an area for potential cost savings •To reduce the total value of medications stored in ADCs on inpatient units without reducing the availability of medications •An ADC inventory report was built in the central automation server set to generate every Monday night •This report was exported into a spreadsheet, where the data was cleaned and valuation data was calculated for every item •High cost items were identified and evaluated for removal or reduction based on usage data •If unused in the last 6 months, items were removed from stock to be dispensed from central pharmacy •If used infrequently, usage data was analyzed to determine a reduced par level •Emergency medications, such as alteplase, were never completely removed •Par levels were reduced where appropriate based on usage history and clinical judgment •In May, MGH transitioned to EPIC, temporarily pausing this project. There was a notable upwards trend in valuations in the months surrounding this transition, largely due to staffing limitations The authors would like to thank Jim Lund, PharmD and April Madrigal, CPhT for their assistance and support during this project •ADC inventory optimization represents an underutilized area of cost avoidance with relatively easy implementation in many hospitals •Next steps at MGH include evaluating medications for addition to the ADC inventory with the goal of increasing the percentage of doses dispensed from the ADC system to reduce turnaround times •Integration of ADC inventory maintenance to pharmacy workflows, rather than the current ad-hoc basis would further streamline this continuous improvement process •Increased use of systems such as those offered by Omnicell and Pandora is currently being explored to help automate fine-tuning of par levels Month Medication Valuation $ Reduction from Start % Reduction from Start Oct-15 $1,331,195 -- --% Nov-15 $1,273,507 $57,689 4% Dec-15 $1,060,670 $270,525 20% Jan-16 $1,032,786 $298,409 22% Feb-16 $926,558 $404,638 30% Mar-16 $952,005 $379,191 28% Apr-16 $991,551 $339,645 26% May-16 $967,296 $363,900 27% Jun-16 $992,787 $338,409 25% Jul-16 $1,012,648 $318,547 24% Aug-16 $847,853 $483,343 36% Sep-16 $855,862 $475,333 36% Oct-16 $885,734 $445,461 33% $1.33 $0.89 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% $- $0.20 $0.40 $0.60 $0.80 $1.00 $1.20 $1.40 10/2015 11/2015 12/2015 1/2016 2/2016 3/2016 4/2016 5/2016 6/2016 7/2016 8/2016 9/2016 10/2016 PercentReductioninADCValuation TotalADCValuation(Millions) Monthly Valuation Percent Reduction